Turning Point Brands: The Modern Oral Bet That Could Redefine or Bury the Legacy Business
Turning Point Brands (TPB) reports Q1 2026 earnings tomorrow, May 7, before market open, with analysts expecting $0.60 per share on revenue estimates around $129 million. The report comes at a critical juncture after the company's Q4 2025 miss sent shares tumbling 20.79% in a single session, raising questions about whether management can stabilize performance across its tobacco alternatives portfolio. Investors will scrutinize segment trends—particularly NewGen vaping and Zig-Zag papers—for signs of recovery or further deterioration.
Part 1: Earnings Preview
Turning Point Brands is a leading provider of Other Tobacco Products (OTP) in the U.S., operating through three main segments: Smokeless Products (Stoker's MST & Chew), Smoking Products (Zig-Zag papers & wraps), and NewGen (vaping through VaporBeast & International Vapor Group, plus hemp-derived products). The diversified portfolio positions TPB as a key player in tobacco alternatives as consumer preferences shift away from traditional cigarettes.
For Q1 2026, the consensus estimate stands at $0.60 per share, a sharp decline from the $0.79 reported in Q1 2025. Most recently, TPB posted $0.42 per share in Q4 2025, badly missing the $0.84 estimate. Year-over-year, the Q1 2026 estimate represents a 24.05% decline from the $0.79 earned in the same quarter last year, signaling analyst concern about near-term headwinds.
Three key themes define this earnings story:
NewGen Segment Pressure: The vaping and hemp-derived products division has faced regulatory uncertainty and competitive intensity. Investors need clarity on whether VaporBeast and International Vapor Group can stabilize volumes and margins, or if the Q4 weakness signals a more structural challenge in the category.
Zig-Zag Brand Performance: As TPB's flagship smoking products brand, Zig-Zag papers and wraps are critical to cash flow generation. Volume trends, pricing power, and market share dynamics in rolling papers will indicate whether the core business can offset NewGen softness.
Margin Defense and Cost Management: With top-line growth under pressure, management's ability to protect gross margins through pricing discipline and operational efficiency becomes paramount. Commentary on input costs, supply chain optimization, and SG&A leverage will be closely watched.
Analyst commentary ahead of the release reflects caution. While three firms maintain Strong Buy ratings with price targets as high as $140, the consensus has deteriorated significantly—estimates for Q1 have been revised down from $0.79 to $0.60 over the past 90 days, and full-year 2026 expectations have dropped from $3.11 to $2.66. The downward revisions suggest analysts are recalibrating expectations for a tougher operating environment across TPB's portfolio.
Part 2: Historical Earnings Performance
TPB's recent earnings track record shows extreme volatility, with the company alternating between significant beats and a dramatic miss. In Q1 2025, TPB reported $0.79 versus a $0.68 estimate, beating by 16.18%. Q2 2025 matched that performance with another $0.79 result against a $0.68 estimate, again beating by 16.18%. The Q3 2025 report delivered the strongest outperformance, with $1.13 crushing the $0.72 estimate by 56.94%.
However, Q4 2025 shattered this positive momentum. TPB reported just $0.42 against an $0.84 estimate, missing by 50.00%—the company's first miss in the trailing four quarters and by far its worst performance. The magnitude of the shortfall suggests operational challenges rather than minor timing issues, raising questions about whether the earlier beats masked underlying weakness or if Q4 represented a one-time disruption.
The pattern reveals a company that has historically exceeded expectations but now faces credibility concerns after the Q4 collapse. With estimates already slashed for Q1 2026, the bar is set lower—but investors will demand evidence that the Q4 miss was an aberration rather than the start of a negative trend.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.68 | $0.79 | +16.18% | Beat |
| Jun 2025 | $0.68 | $0.79 | +16.18% | Beat |
| Sep 2025 | $0.72 | $1.13 | +56.94% | Beat |
| Dec 2025 | $0.84 | $0.42 | -50.00% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
TPB typically reports before market open, meaning Day 0 captures the first full trading session reaction while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-03-02 | -$28.48 (-20.79%) | $14.14 (10.32%) | -$0.94 (-0.87%) | $6.32 (5.82%) |
| 2025-11-05 | +$5.98 (+6.28%) | $16.05 (16.87%) | -$0.97 (-0.96%) | $6.93 (6.85%) |
| 2025-08-06 | +$11.54 (+14.22%) | $12.90 (15.90%) | +$1.46 (+1.58%) | $4.55 (4.91%) |
| 2025-05-07 | +$16.11 (+24.83%) | $8.80 (13.56%) | -$5.34 (-6.59%) | $5.47 (6.76%) |
| 2025-03-06 | -$5.46 (-8.15%) | $8.97 (13.38%) | -$0.28 (-0.45%) | $3.87 (6.29%) |
| 2024-11-07 | -$1.44 (-2.82%) | $4.47 (8.75%) | +$2.09 (+4.21%) | $2.80 (5.65%) |
| 2024-08-01 | +$0.50 (+1.33%) | $3.63 (9.62%) | -$0.98 (-2.56%) | $1.35 (3.53%) |
| 2024-05-02 | +$3.38 (+11.58%) | $2.14 (7.34%) | +$0.16 (+0.49%) | $1.65 (5.07%) |
| Avg Abs Move | 11.25% | 11.97% | 2.21% | 5.61% |
Historical price behavior around earnings reveals substantial volatility, with an average absolute Day 0 move of 11.25% and Day 0 range of 11.97%. The most recent Q4 2025 report triggered a devastating 20.79% decline on Day 0, the largest single-session drop in the dataset. Prior to that, Q1 2025 delivered a massive 24.83% surge, while Q2 2025 gained 14.22%—demonstrating TPB's tendency to make outsized moves in either direction.
Day +1 follow-through is more muted but still meaningful, averaging 2.21% with a 5.61% range. The Q1 2025 report saw a 6.59% reversal on Day +1 after the initial surge, suggesting profit-taking after extreme moves. Investors should prepare for significant volatility tomorrow, with historical precedent pointing to double-digit percentage swings as the norm rather than the exception for TPB earnings reactions.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 9) |
| Expected Move | $3.40 (4.18%) |
| Expected Range | $77.86 to $84.66 |
| Implied Volatility | 103.82% |
The options market is pricing a 4.18% expected move through the May 15 expiration, implying a range of $77.86 to $84.66. This is substantially below TPB's historical average Day 0 move of 11.25%, suggesting options traders may be underestimating potential volatility or that the Q4 collapse has reset expectations for more contained reactions going forward.
Part 3: What Analysts Are Saying
Analyst sentiment on TPB shows a divided Street with a cautious tilt. The current consensus rating stands at 3.80 (between Hold and Buy), with an average price target of $131.25—implying 61.5% upside from the current $81.26 price. The rating breakdown reveals 3 Strong Buys, 1 Hold, and 1 Strong Sell, with price targets ranging from $125 to $140.
Sentiment has remained unchanged over the past month, with the same 3-0-1-0-1 distribution holding steady. However, this stability masks significant estimate revisions—two analysts have cut their Q1 estimates in the past 30 days, and three have reduced full-year 2026 projections. The disconnect between maintained ratings and slashed estimates suggests analysts are giving management the benefit of the doubt while acknowledging near-term challenges.
The $131.25 consensus target represents substantial upside, but the wide range ($125 to $140) reflects uncertainty about TPB's ability to execute. The single Strong Sell rating serves as a reminder that not all analysts are convinced the company can navigate current headwinds, particularly in the NewGen segment where regulatory and competitive pressures remain intense.
Part 4: Technical Picture
TPB enters earnings in a deteriorating technical position, with the Barchart Technical Opinion showing a 72% Sell signal—an improvement from last week's 88% Sell but still firmly bearish. The signal has weakened considerably from last month's 40% Sell, reflecting the stock's struggle to find footing after the Q4 earnings collapse.
Timeframe Analysis:
- Short-term (50% Sell): Moderate sell signal indicates near-term momentum remains negative but less extreme than recent weeks
- Medium-term (100% Sell): Strong sell signal across all medium-term indicators suggests the intermediate trend is firmly bearish
- Long-term (50% Sell): Moderate sell signal reflects weakness in the longer-term trend structure
The trend characteristics show Good strength with Average direction, suggesting the current downtrend has conviction but may be approaching a potential inflection point where directional clarity could emerge from the earnings catalyst.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $81.43 | 50-Day MA | $87.70 |
| 10-Day MA | $79.51 | 100-Day MA | $102.67 |
| 20-Day MA | $79.70 | 200-Day MA | $98.81 |
The stock trades at $81.26, positioned below all major long-term moving averages—below the 50-day at $87.70, the 100-day at $102.67, and the 200-day at $98.81. However, TPB has recently reclaimed its short-term averages, trading above the 10-day at $79.51 and 20-day at $79.70, while sitting just below the 5-day at $81.43. This positioning suggests a potential short-term stabilization attempt within a broader downtrend. The technical setup is cautionary heading into earnings, with the stock needing a significant positive catalyst to break above resistance at the 50-day moving average and reverse the medium-term bearish structure. Given the historical volatility around TPB earnings and the current oversold conditions, tomorrow's report could either confirm the breakdown or spark a sharp relief rally if results exceed the lowered bar.